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Objective. To examine the eﬀect of acute and short-term (∼1 week) aerobic exercise training on plasma adiponectin levels in inac-
tive, abdominally obese men. Materials and Methods. Inactive and abdominally obese men (n = 38, waist circumference ≥102cm)
recruited from Kingston, Canada were randomly allocated to perform three bouts of aerobic treadmill exercise at either low
(50% VO2 peak) or high (75% VO2 peak) intensity during a 1-week period. Blood samples were taken before and after the ﬁrst
exercise session and 24–72 hours following the completion of the ﬁnal exercise session. Results. Adiponectin levels were elevated
immediately following an acute bout of exercise at both high and low intensities (High: 5.79±0.42 versus 5.05±0.41ug/mL; Low:
5.24 ± 0.44 versus 4.37 ± 0.44ug/mL, P<0.05) and remained elevated following 30 minutes of rest. In comparison to baseline,
adiponectin levels were also elevated 24–72 hours following the ﬁnal exercise session (High: 5.47 ±0.48 versus 4.88 ±0.48ug/mL;
Low: 5.18±0.49 versus 4.47±0.49ug/mL, P<0.05). Conclusion. Both acute and short-term aerobic exercise result in a signiﬁcant
increase in plasma adiponectin levels in inactive, abdominally obese men independent of intensity.
1.Introduction
Obesity and related metabolic disorders are among the most
important public-health concerns in developed nations [1].
One possible target for the reduction of obesity-related car-
diometabolic risk is adiponectin, an adipokine with insulin-
sensitizing and antiatherogenic properties, which circulates
at levels inversely proportional to both total and abdominal
fat mass [2–4]. Evidence suggests that an acute bout of
vigorous aerobic exercise may result in a signiﬁcant increase
inplasmaadiponectinlevelsintrainedathletes,althoughthis
increase is not apparent until 30 minutes after the cessation
of exercise [5–7]. In contrast, immediately following the
cessation of exercise, adiponectin levels are reported to be
unchanged [5] or even reduced [7] in trained individuals.
Further, evidence also suggests that an acute bout of aerobic
exercise at a moderate intensity has little or no impact on
adiponectin levels in healthy, but untrained populations [8].
At present the relationship between an acute bout of
aerobic exercise and adiponectin levels in inactive, abdomi-
nallyobeseindividualsisunclear.Twostudieshaveexamined
adiponectin levels immediately after exercise in this popula-
tion [9, 10] and report that adiponectin levels are decreased
[10] or unchanged [9]. However, to date no studies have2 J o u r n a lo fN u t r i t i o na n dM e t a b o l i s m
examined adiponectin levels in abdominally obese individu-
als 30 minutes after the cessation of an acute bout of aerobic
exercise, the time point when adiponectin has been reported
to be increased in athletic populations [5, 7].
At present it is also unclear whether one week of aerobic
exercise training is associated with an increase in plasma
adiponectin levels in individuals with abdominal obesity.
Kriketos et al. [11] report that 2 to 3 bouts of aerobic exercise
spread over one week resulted in a dramatic 11.2μg/mL
(equivalent to 160% of baseline values) increase in plasma
adiponectin levels in inactive, abdominally obese men. An
increase of this magnitude, however, is diﬃcult to reconcile
with other evidence. A recent systematic review reports that
the average adiponectin increase observed in response to
chronic exercise across all populations is just 1.33μg/mL,
with the majority of studies, including those involving up to
24 weeks of regular exercise, failing to observe a signiﬁcant
change in adiponectin levels following the intervention [8].
Further, investigations of pharmacotherapy suggest similar
small-to-moderate eﬀects on adiponectin levels [12]. To our
knowledge, the eﬀect of a single week of aerobic training on
adiponectin levels in a population of inactive and abdomi-
nally obese individuals has yet to be investigated, or corrob-
orated, by any subsequent interventions.
Given the high prevalence of both hypoadiponectinemia
and cardiometabolic risks among abdominally obese indi-
viduals [4], it is important to improve our understanding of
the relationship between exercise and adiponectin levels in
this high-risk population. The purpose of the present study
was to examine the eﬀect of both acute and short-term (∼1
week) aerobic exercise training on plasma adiponectin levels
in inactive, abdominally obese men. We also sought to deter-
mine whether exercise intensity inﬂuences the response to
plasma adiponectin levels in this population, independent of
caloric expenditure. We hypothesized that adiponectin levels
would be signiﬁcantly decreased immediately following a
bout of acute exercise, but signiﬁcantly increased 30 minutes
after the cessation of exercise, as well as after one week of
aerobictraining.Wealsohypothesizedthatforagivenenergy
expenditure, exercising at 75% of VO2 peak would have a
greater impact on adiponectin levels than exercising at 50%
of VO2 peak.
2.MaterialsandMethods
2.1. Participants. Participants included 38 abdominally obese
men (waist circumference ≥1 0 2 c m )a g e d2 5t o5 0y e a r s .
All participants reported being weight stable (±1kg)for6
months prior to the study and engaged in physical activity
less than once per week. Potential participants were excluded
from the study if they reported smoking or had a history
of heart disease, stroke, or diabetes or were taking glucose-
lowering medication. The use of lipid-lowering (e.g., statins)
and hypertension (e.g., angiotensin-converting enzyme inhi-
bitors)medicationswaspermitted.Allparticipantsgavetheir
informed written consent before participation in accordance
with the ethical guidelines set by Queen’s University. Partici-
pantswereinstructedtomaintaintheirusualdietthroughout
the duration of the study.
2.2. Anthropometric Measurements. Body mass was mea-
sured to the nearest 0.1kg on a calibrated balance. Standing
height was measured to the nearest 0.1cm with the use of
a wall-mounted stadiometer. Waist circumference (WC) was
measured at the superior border of the iliac crest and was
taken to the nearest 0.1cm after a normal expiration.
2.3. Cardiorespiratory Fitness. Cardiorespiratory ﬁtness
(measured as oxygen consumption per unit of time (VO2
peak)) was determined using results of a maximal treadmill
test combined with standard open-circuit spirometry tech-
niques (SensorMedics Corp, Yorba Linda, California) at
baseline. Fitness testing took place at least one week prior to
the beginning of the exercise protocol for all participants.
2.4. Exercise Protocol. Participants were randomly allocated
to High- or Low-intensity treadmill exercise groups using a
random number table. Group allocation was not revealed to
individualparticipantsuntiltheyarrivedattheirﬁrstexercise
session. The High-intensity group exercised at a heart rate
approximating an intensity of 75% of VO2 peak, while the
Low-intensity group exercised at an intensity of 50% VO2
peak, as determined by the prestudy ﬁtness test. The length
of the exercise session was adjusted to ensure that each par-
ticipant expended an estimated 400 calories per exercise
session in order to investigate the impact of exercise intensity
while keeping expenditure constant. Participants in both
groups performed three bouts of aerobic exercise within one
week, with one- to two-days of rest between each session.
2.5. Blood Samples and Biochemistry. All blood samples were
taken following an overnight 12-hour fast. 10mL of blood
was taken from the antecubital vein immediately before,
immediatelyafter,and30minutesafterthecompletionofthe
ﬁrst exercise session. Blood samples were also taken 24–72
hours following the third and ﬁnal exercise session. Plasma
glucose was measured using an automated glucose analyzer
(YSI 2300 Glucose Analyzer; YSI, Yellow Springs, OH).
HDL-cholesterol and triglyceride levels were measured using
enzymatic methods on the Roche Modular analytical system
(Roche Diagnostics, Indianapolis, IN). Plasma adiponectin
concentrations were determined using an enzyme-linked
immunosorbent assay (B-Bridge International, Inc., San
Jose, CA) of whole plasma kept at −80◦Cb e f o r eu s e .A l l
adiponectin measurements were performed centrally at the
Cardiovascular Risk Factor Laboratory at the Quebec Heart
and Lung Institute at Universit´ eL a v a l ,Q u´ ebec, Canada, and
samples were shipped frozen using dry ice. Shifts in plasma
v o l u m ed u r i n gt h ea c u t eb o u to fe x e r c i s ew e r ec a l c u l a t e d
using the method outlined by Dill and Costill [13].
2.6. Statistics. T-tests were used to compare baseline values
between the two groups. A mixed-eﬀect model with random
intercept was used to assess changes in markers of car-
diometabolic risk following a single session of aerobic exer-
cise, as well as 24–72 hours after the third and ﬁnal session of
aerobicexercise.Thefollowingvariableswereincludedinthe
mixed-eﬀect model for acute exercise: time of blood draw,J o u r n a lo fN u t r i t i o na n dM e t a b o l i s m 3
Table 1: Participant characteristics.
Low (n = 18) High (n = 20)
Age 38.39 (11.2) 38.95 (7.6)
BMI (kg/m2) 33.00 (3.8) 33.96 (3.6)
Waist circumference (cm) 112.97 (8.7) 117.10 (8.9)
Systolic blood pressure (mmHg) 124.33 (15.7) 116.65 (30.1)
Diastolic blood pressure (mmHg) 82.94 (7.8) 77.2 (19.8)
VO2 peak (mL/kg/min) 32.00 (4.59) 32.83 (6.1)
Exercise volume (min) 48.6 (6.6) 30.75 (6.1)∗
Average intensity (% of max) 47.9% (3.9) 72.6% (4.3)∗
Calories burned (kcal) 383.32 (36.2) 394.4 (29.7)
Data are presented as mean (Standard Deviation).
∗Signiﬁcantly diﬀerent from the Low group, P ≤ 0.05.
Table 2: Acute changes in markers of cardiometabolic risk following one bout of aerobic exercise.
Group Before exercise Following exercise Following exercise + 30
Adiponectin (ug/mL) High 5.05 (0.41) 5.79 (0.42)∗ 5.69 (0.42)∗
Low 4.37 (0.44) 5.24 (0.44)∗ 5.11 (0.44)∗
Triglycerides (mmol/L) High 1.98 (0.24) 2.10 (0.24) 1.77 (0.24)∗
Low 2.04 (0.26) 2.09 (0.26) 1.93 (0.26)
HDL cholesterol (mmol/L) High 1.04 (0.053) 1.06 (0.054) 0.99 (0.053)
Low 0.81 (0.056) 0.88 (0.056) 0.84 (0.059)
LDL cholesterol (mmol/L High 3.62 (0.23) 3.60 (0.23) 3.53 (0.23)
Low 2.89 (0.25) 2.90 (0.25) 2.86 (0.25)
Insulin (pmol/L) High 85.05 (7.74) 85.63 (7.47) 91.63 (9.11)
Low 108.38 (24.67) 68.25 (11.27) 79.44 (14.85)
Glucose (mmol/L) High 5.44 (0.15) 5.60 (0.16) 5.45 (0.15)
Low 4.83 (0.17) 4.75 (0.17)† 4.73 (0.17)†
Data presented as mean (standard error). All acute data are controlled for changes in plasma volume.
∗Signiﬁcantly diﬀerent from baseline, P ≤ 0.05, using Bonferroni correction.
†Signiﬁcantly diﬀerent from High-intensity group at the same time point P ≤ 0.05, using Bonferroni correction.
group of participant, and changes in plasma volume. For
short-term exercise, changes in plasma volume were omitted
from the model. Statistical signiﬁcance was deﬁned as a P
value of 0.05 or less, and a Bonferroni correction was used to
adjust for multiple comparisons in post hoc tests following
the mixed-eﬀect model. All analyses of acute changes are
controlled for changes in plasma volume.
Variables which exhibited nonnormal distributions were
transformed prior to analysis using a log transformation.
Five participants (3 from the High group, 2 from the Low
group) participated in only the ﬁrst exercise session and were
thus excluded from analyses examining the impact of 3 exer-
cise sessions on markers of metabolic risk. All analyses were
performed using SAS 9.2 and SPSS 18.0.
3. Results
Participant characteristics are presented in Table 1. Table 2
displays values of adiponectin and other markers of car-
diometabolic risk before and after a single session of aerobic
exercise. Exercise at either a High- or Low-intensity resulted
in a signiﬁcant increase in adiponectin levels both immedi-
ately (High: P = 0.003; Low: P<0.0001) and 30 minutes
after exercise (High: P = 0.0137; Low: P = 0.008). There
was no signiﬁcant group by time interaction (P = 0.8276).
In comparison to baseline, triglyceride levels remained
unchanged immediately following exercise in both groups
(High: P = 0.2103; Low: P = 1.0) but were signiﬁcantly
decreased in the High-intensity group 30 minutes subse-
quent to exercise (P = 0.009). There was a borderline signiﬁ-
cant reduction of insulin levels immediately following the
cessation of exercise in the Low-intensity group (P = 0.053),
although they were no diﬀerent from baseline 30 minutes
following the cessation of exercise (P = 1.0). No changes
in insulin levels were observed in the High-intensity group
(P>0.05). Acute exercise did not result in any signiﬁcant
changes in any other marker of cardiometabolic risk (see
Table 2), and changes in adiponectin were not associated
with changes in any other marker of cardiometabolic risk
(data not shown, P>0.05).
Table 3 presents the levels of adiponectin and other
markers of cardiometabolic risk before and after three
sessions of aerobic exercise training at either a High or Low
intensity. As expected, there were no signiﬁcant changes in
bodyweightorwaistcircumferenceineithergroupfollowing
one week of aerobic training (P>0.05). Adiponectin levels4 J o u r n a lo fN u t r i t i o na n dM e t a b o l i s m
Table 3: Changes in markers of cardiometabolic risk following one week of aerobic exercise training.
Group Before training After training
Adiponectin (ug/mL) High 4.86 (0.48) 5.47 (0.48)∗
Low 4.47 (0.49) 5.18 (0.49)∗
Triglycerides (mmol/L) High 2.07 (0.27) 1.71 (0.27)
Low 2.06 (0.28) 2.27 (0.27)
HDL Cholesterol (mmol/L) High 1.04 (0.059) 1.00 (0.06)
Low 0.77 (0.061)† 0.95 (0.06
LDL Cholesterol (mmol/L High 3.58 (0.25) 3.48 (0.25)
Low 2.91 (0.25) 3.07 (0.25)
Insulin (pmol/L) High 85.05 (7.74) 73.00 (10.52)
Low 108.38 (24.67) 90.13 (15.15)
Glucose (mmol/L) High 5.36 (0.15) 5.55 (0.15)
Low 4.92 (0.17) 5.05 (0.16)
Weight (kg) High 114.48 (4.03) 114.49 (4.03)
Low 105.42 (4.16) 104.72 (4.16)
Waist Circumference (cm) High 118.50 (2.07) 117.55 (2.07)
Low 112.92 (2.13) 112.71 (2.14)
Data presented as mean (standard error).
∗Signiﬁcantly diﬀerent from baseline, P ≤ 0.05, using Bonferroni correction.
†Signiﬁcantly diﬀerent from High-intensity group at the same time point P ≤ 0.05, using Bonferroni correction.
were signiﬁcantly elevated in all participants 24–72 hours
after the ﬁnal exercise session (P<0.05), and these values
were not signiﬁcantly diﬀerent from those observed fol-
lowing an acute bout of aerobic exercise (P>0.05) (see
Figure 1). There was no signiﬁcant group by time interaction
(P = 0.6635).Threesessionsofaerobicexercisedidnotresult
insigniﬁcantchangesinanyothermarkerofcardiometabolic
risk (P>0.05). Changes in adiponectin were not associated
with changes in any marker of cardiometabolic risk except
for fasting glucose (r = 0.40, P = 0.0234).
4. Discussion
The present ﬁndings support our original hypotheses and
suggest that an acute bout of aerobic exercise results in a sig-
niﬁcant increase in plasma adiponectin levels in abdominally
obese men. Further, three sessions of aerobic exercise within
a one-week period were suﬃcient to maintain this increase
for 1–3 days after the ﬁnal exercise session. It is worth noting
that the increases in adiponectin observed in the present
study occurred in the absence of any changes in weight
or waist circumference. As such, these ﬁndings add to the
growing body of evidence showing that exercise results in
important health beneﬁts irrespective of changes in body
weight [14, 15].
The current ﬁndings are in agreement with previous
work which has reported that vigorous exercise is associated
withanacuteincreaseinplasmaadiponectinlevelsintrained
athletes [5, 7]. These results also support the ﬁndings of
Kriketos et al. [11], who report that one week of aerobic
training results in increased adiponectin levels in abdom-
inally obese men. It should be noted, however, that the
increase in adiponectin levels following one week of training
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Figure 1: Changes in adiponectin following aerobic exercise in
abdominally obese men. ∗Signiﬁcantly diﬀerent than before exer-
cise in both groups, P<0.05. Groups are presented as High- ()
and Low- () intensity exercise. Plasma volume was not assessed at
the ﬁnal blood draw, and thus values in this ﬁgure have not been
adjusted for changes in plasma volume.
in the present study was of a much smaller magnitude than
what has been reported previously [11].
In contrast to our hypothesis, the increase in adiponectin
levels following a session of acute exercise was detectable
immediately following the cessation of exercise. These results
diﬀerfromtherecentﬁndingsofNumaoandcolleagues[10],
who report that adiponectin levels in abdominally obese
men are signiﬁcantly reduced immediately following the ces-
sation of aerobic exercise at a high intensity and unchanged
immediatelyfollowingaerobicexerciseatalowintensity.The
reasons for these discrepant ﬁndings are not immediatelyJ o u r n a lo fN u t r i t i o na n dM e t a b o l i s m 5
clear.Onediﬀerenceworthnoting,however,wasthatpartici-
pants in the present study were almost exclusively Caucasian,
while those involved in the study of Numao and colleagues
were Japanese. Adiponectin has been shown to circulate in
isoforms of varying molecular weights [16], and it has been
reported that the relative proportions of these isoforms,
and their relationships with disease, diﬀer by ethnicity [17,
18]. For example, it has been reported that Indo-Asian
women have a signiﬁcantly lower proportion of high molec-
ular weight adiponectin than their Caucasian peers [18].
Of note, Numao and colleagues report that although cir-
culating levels of both medium- and low-molecular weight
adiponectin decreased immediately following a bout of
vigorous aerobic exercise, the proportion of high molecular
weight adiponectin was signiﬁcantly increased [10]. Thus, it
is possible that ethnic diﬀerences in the relative proportions
of adiponectin isoforms, or the response of these isoforms
to acute exercise, may inﬂuence the relationship between
exercise and total adiponectin levels. Unfortunately, the dis-
tribution of adiponectin isoforms was not assessed in the
present study.
Diﬀerences between the current ﬁndings and those of
Numao may also be related to the mode of exercise employed
by the two studies. To our knowledge, only studies which
have employed vigorous whole-body exercise report an acute
increase in plasma adiponectin levels [5, 7]. In contrast, par-
ticipants in the recent report by Numao et al. [10]pe rf o rm ed
exercise on a cycle ergometer, which may have engaged fewer
musclegroupsthanthecurrentintervention.Futureresearch
is needed to clarify the reasons behind these divergent
ﬁndings.
4.1. Potential Mechanisms. Although it was once thought
that adiponectin was produced exclusively in adipocytes,
recent evidence suggests that adiponectin is also actively
secreted by myocytes [19–21]. Further, Amin and colleagues
have shown that the PPARγ agonist rosiglitazone induces a
signiﬁcant increase in muscle adiponectin production [19].
Acute exercise has also been shown to result in rapid changes
in the transcription of PPARγ coactivator Pgc-1α in skeletal
muscle, suggesting that this pathway may link acute exercise
with adiponectin production at the level of the myocyte
[22, 23]. However, to our knowledge no studies have yet
examined the role of exercise in adiponectin production in
muscle cells.
Although both insulin and catecholamine levels have
been suggested to play a role in acute changes in adiponectin
levels [7, 10, 24], they seem unlikely to explain the increases
in adiponectin observed in the present study. In the present
study,adiponectinlevelswereelevatedabovebaselineinboth
groups at all postexercise time points, while insulin levels
were only reduced at one time point (immediately following
exercise) in one group (Low). This suggests that changes in
insulin levels are not the primary mediator of the observed
change in adiponectin levels. The role of catecholamines in
this process is also unclear. While they are thought to play a
largely inhibitory role in adiponectin expression [10, 25], it
has also been shown that catecholamine levels are increased
followingvigorousexercise[26],whichsuggeststhattheytoo
are unlikely to explain the present ﬁndings.
The present study has several strengths and limita-
tions which warrant mention. As mentioned previously, the
present analysis focused solely on total adiponectin concen-
trations, rather than looking at concentrations of speciﬁc
adiponectinoligomers.Thecurrentstudyalsofocusedexclu-
sivelyonarelativelyhomogeneousgroupofinactive,abdom-
inally obese adult males, and thus our ﬁndings may not
translatetofemalesortoindividualswithagesorphenotypes
diﬀerent from those of participants in the current sample.
While this may limit the generalizability of these results to
other groups, the population studied in the current investi-
gation is at substantially increased risk of hypoadiponectine-
mia and cardiometabolic dysfunction [4]. As a result, inter-
ventions which are able to increase adiponectin levels in
this population could have important clinical applications.
Finally, the current investigation also beneﬁts from a ran-
domized design and the tight monitoring and control of
exercise intensity for participants in both groups.
In summary these ﬁndings suggest that an acute bout
of exercise, regardless of exercise intensity, results in a
signiﬁcant increase in plasma adiponectin levels in inactive,
abdominally obese men. Further, an acute bout of exercise at
high, but not low, intensity also results in a signiﬁcant reduc-
tion in plasma triglyceride levels in these same individuals.
Finally, adiponectin levels remained elevated 24–72 hours
after completing 3 exercise sessions in a one-week period.
These changes were observed in the absence of any change
in weight or body composition. These results suggest that
positive changes in adiponectin levels may be yet another
important health beneﬁt observed with even a single session
of aerobic exercise.
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